What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

Overview of attention for article published in Annals of General Psychiatry, March 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 439 followers.

Modificaciones de tratamiento con ISRS: se eligió el doble de veces añadir un segundo fármaco en vez de cambiarlo http://t.co/tm7P22MZbL

La mitad de los que fueron tratados con ISRS como primer tratamiento, recibieron después un segundo tratamiento http://t.co/tm7P22MZbL

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.